Treatment of Early Nasal Polyposis With Topical Triamcinolone
Stopped early · Phase 1/Phase 2
Conditions studied: Nasal Polyps
In brief
The purpose of this study is to compare the effectiveness of intranasal Triamcinolone delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked dressing, in the treatment and prevention of early nasal polyposis.
Key facts
- Study ID
- NCT01222871
- Run by
- Steward St. Elizabeth's Medical Center of Boston, Inc.
- People needed
- 1
- Starts
- 2010-07-01
- Expected to finish
- 2012-08-01
- Last updated by the study team
- 2018-06-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age > 18 years
- Patients with early nasal polyposis
You may not qualify if…
- Age < 18 years
- Patients with active sinus infections
- Patients on long term steroids
- Allergy or sensitivity to steroids
- Patients with Antrochoanal polyps
- Patients who received topical steroids by bio-resorbable sponge or oral steroids
Where it is running
- St. Elizabeth's Medical Center, 736 Cambridge St — Brighton, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.